- Home
- BBOT vs CIVB Comparison
BBOT vs CIVB Comparison
Compare BBOT & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBOT | CIVB |
|---|---|---|
| Founded | 2016 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 717.8M | 592.8M |
| IPO Year | 2024 | 2012 |
Fundamental Metrics
Financial Performance| Metric | BBOT | CIVB |
|---|---|---|
| Price | $9.61 | $27.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $24.00 | ★ $26.60 |
| AVG Volume (30 Days) | ★ 254.2K | 110.5K |
| Earning Date | 05-26-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | ★ 99.93 | 31.34 |
| EPS | N/A | ★ 1.41 |
| Revenue | N/A | ★ $19,023,000.00 |
| Revenue This Year | N/A | $14.88 |
| Revenue Next Year | N/A | $5.99 |
| P/E Ratio | ★ N/A | $20.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.00 | $19.76 |
| 52 Week High | $14.87 | $29.97 |
Technical Indicators
Market Signals| Indicator | BBOT | CIVB |
|---|---|---|
| Relative Strength Index (RSI) | 60.86 | 43.50 |
| Support Level | $7.99 | $27.97 |
| Resistance Level | $11.02 | $29.31 |
| Average True Range (ATR) | 0.48 | 0.54 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 87.94 | 1.49 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.